66 related articles for article (PubMed ID: 38398766)
1. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
3. Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications.
Bumbasirevic U; Petrovic M; Zekovic M; Coric V; Milojevic B; Lisicic N; Obucina D; Vasilic N; Bulat P; Zivkovic M; Cekerevac M; Bojanic N; Janicic A
Life (Basel); 2024 Feb; 14(2):. PubMed ID: 38398766
[TBL] [Abstract][Full Text] [Related]
4. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
Favilla V; Russo GI; Spitaleri F; Urzì D; Garau M; Madonia M; Saita A; Pirozzi Farina F; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
Int Urol Nephrol; 2014 Jun; 46(6):1131-5. PubMed ID: 24318367
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of intratubular germ cell neoplasia and multifocality in testicular germ cell tumors ≤ 2 cm: relationship with other pathological features.
Favilla V; Russo GI; Spitaleri F; Urzì D; Madonia M; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
Clin Genitourin Cancer; 2015 Feb; 13(1):e31-5. PubMed ID: 24996692
[TBL] [Abstract][Full Text] [Related]
6. Multifocality in testicular germ cell tumors.
Ehrlich Y; Konichezky M; Yossepowitch O; Baniel J
J Urol; 2009 Mar; 181(3):1114-9; discussion 1119-20. PubMed ID: 19150559
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
8. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023.
Stephenson A; Bass EB; Bixler BR; Daneshmand S; Kirkby E; Marianes A; Pierorazio PM; Sharma R; Spiess PE
J Urol; 2024 Jan; 211(1):20-25. PubMed ID: 37707243
[TBL] [Abstract][Full Text] [Related]
10. Treatment options in stage I seminoma.
Bumbasirevic U; Zivkovic M; Petrovic M; Coric V; Lisicic N; Bojanic N
Oncol Res; 2022; 30(3):117-128. PubMed ID: 37305015
[TBL] [Abstract][Full Text] [Related]
11. European Association of Urology Guidelines on Testicular Cancer: 2023 Update.
Patrikidou A; Cazzaniga W; Berney D; Boormans J; de Angst I; Di Nardo D; Fankhauser C; Fischer S; Gravina C; Gremmels H; Heidenreich A; Janisch F; Leão R; Nicolai N; Oing C; Oldenburg J; Shepherd R; Tandstad T; Nicol D
Eur Urol; 2023 Sep; 84(3):289-301. PubMed ID: 37183161
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Systemic Inflammation Markers in Testicular and Penile Cancer: A Narrative Review of Current Literature.
Janicic A; Petrovic M; Zekovic M; Vasilic N; Coric V; Milojevic B; Zivkovic M; Bumbasirevic U
Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983756
[TBL] [Abstract][Full Text] [Related]
13. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Amin MB; Berney DM; Compérat EM; Gill AJ; Hartmann A; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Netto GJ
Eur Urol; 2022 Nov; 82(5):458-468. PubMed ID: 35853783
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer.
Jaipuria J; Ahmed HU
Curr Opin Urol; 2022 May; 32(3):224-230. PubMed ID: 35184067
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.
Leão R; Albersen M; Looijenga LHJ; Tandstad T; Kollmannsberger C; Murray MJ; Culine S; Coleman N; Belge G; Hamilton RJ; Dieckmann KP
Eur Urol; 2021 Oct; 80(4):456-466. PubMed ID: 34175151
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
